David Larson
Analyst, BTIG
Replay available
LifeMD, Inc. (NASDAQ: LFMD) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.

Analyst, BTIG
Analyst, KeyBank Capital Markets
Chairman and Chief Executive Officer
Chief Financial Officer
Analyst, Cantor Fitzgerald
Analyst, H.C. Wainwright & Co.
Good afternoon and thank you for joining us today to discuss LifeMD's results for the second quarter ending June 30, 2026. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer, and Atul Kavthekar, Chief Financial Officer. Following management's prepared remarks, we will open the call for a question and answer session. Before we begin, I would like to remind everyone that during this call, the company will make a number of forward-looking statements which are subject to numerous risks and uncertainties that may cause actual results to differ materially from those projected. These risks and uncertainties are described in the company's 10-K and 10-Q filings and in other filings Life NB may make with the SEC from time to time. Forward-looking statements made during this call are based on information available to the company as of today, August 5, 2026. The company assumes no obligation to update or revise any forward-looking statements after today's call, except as required by law. Management will also discuss certain non-GAAP financial measures that the company believes are useful in evaluating its performance. Reconciliation to the Most Comparable Gap Measures can be found in the press release issued earlier today. Today's call is being recorded and will be available for replay in the investor relations section of the company's website. Now I would like to turn the call over to LifeMD's Chairman and Chief Executive Officer, Justin Schreiber. Justin? Thank you, Operator, and good afternoon, everyone. After the market closed today, We issued our second quarter earnings release and filed our Form 10-Q. We've also posted an updated investor presentation on our investor relations website. I encourage everyone to review those materials. I want to...